About Millbont Pharmaceuticals Private Limited
Data last updated:
Millbont Pharmaceuticals Private Limited is a private limited company based in Udaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 August 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2007PTC024894. Its GSTIN is 08AAFCM2272E1ZN (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Harsh Gupta and Arvind Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 Cb Madhuvan Hospital Road, Udaipur, Rajasthan, India – 313001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.7 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹30.21 Lakh (net margin 17.7%) and EBITDA of ₹44.25 Lakh (EBITDA margin 26%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
The company is associated with 1 brand: Millbont Pharmaceuticals. As per MCA filings, the company has open charges of ₹24 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website millbont.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address4 Cb Madhuvan Hospital Road, Udaipur, Rajasthan, India – 313001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Millbont Pharmaceuticals Private Limited
The main business activity of Millbont Pharmaceuticals is support service to organizations. In detail, this covers other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Millbont Pharmaceuticals Private Limited FY 2025 filings available
Millbont Pharmaceuticals Private Limited reported revenue of ₹1.7 Cr (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Millbont Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 12% fall in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Millbont Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹44.25 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹30.21 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Millbont Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 17.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Millbont Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Millbont Pharmaceuticals Private Limited
Millbont Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Raghav Sai Pharmaceuticals Pvt.Ltd. | ₹1.72 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Hyderabad-434., Telangana, India |
| Suprv Innovations Private Limited | ₹1.71 Cr (FY 2025) | •••• | •••• | 2806.0% | •••• | Navi Mumbai, Maharashtra, India |
| George & Gem's Pharmaceuticals Private Limited | ₹1.71 Cr (FY 2025) | •••• | •••• | -46.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Quora Pharmaceuticals Private Limited | ₹1.71 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Thane, Maharashtra, India |
| Plus Healthcare Solutions Private Limited | ₹1.71 Cr (FY 2023) | •••• | •••• | -26.0% | •••• | Banjara Hills, Telangana, India |
| Millbont Pharmaceuticals Private Limited this company | ₹1.7 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Udaipur, Rajasthan, India |
| Cerys Pharmaceuticals Private Limited | ₹1.7 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Sion, Maharashtra, India |
| Ahinsa Medico Private Limited | ₹1.7 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Delhi, India |
| Ayati Pharma Private Limited | ₹1.7 Cr (FY 2024) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
| Asha Lifesciences Private Limited | ₹1.7 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Lucknow, Uttar Pradesh, India |
| Orwin Biotech Private Limited | ₹1.7 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Panchkula, Haryana, India |
Peers are the five companies nearest above and the five nearest below Millbont Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Millbont Pharmaceuticals Private Limited
Millbont Pharmaceuticals Private Limited is audited by PRITESH JAIN & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRITESH JAIN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Millbont Pharmaceuticals Private Limited
Millbont Pharmaceuticals has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harsh Gupta | Director | 26 Sep 2020 | 6 Years 0 Months | Current |
| Arvind Kumar Gupta | Director | 24 Aug 2007 | 19 Years 1 Months | Current |
| Dinesh Kumar Gupta | Director | 24 Aug 2007 | 19 Years 1 Months | Current |
| Anant Gupta | Director | 03 Oct 2014 | 12 Years 0 Months | Current |
| Kalpana Gupta | Director | 24 Aug 2007 | 19 Years 1 Months | Current |
Ownership and Shareholding of Millbont Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Millbont Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2015 | State Bank of India | ₹14 Lakh | Open |
| 29 Aug 2008 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 2 View all charges
Associated Brands with Millbont Pharmaceuticals Private Limited
Millbont Pharmaceuticals operates one associated brand: Millbont Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulation, development, and delivery of affordable medications in India. | millbont.com |
Employees and EPFO Compliance at Millbont Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Millbont Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Millbont Pharmaceuticals Private Limited
Millbont Pharmaceuticals Private Limited has 6 board changes on record since 2007: 5 appointments and 1 cessation. The latest: Hari Prasad Gupta ceased to be Director on 27 Mar 2024.
Credit Ratings, Litigation & Regulatory Alerts for Millbont Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Millbont Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Millbont Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Millbont Pharmaceuticals Private Limited
Millbont Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAFCM2272E1ZN | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Millbont Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Millbont Pharmaceuticals Private Limited
Millbont Pharmaceuticals is an active private limited company based in Udaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 August 2007 (19+ years old) and is registered under CIN U24232RJ2007PTC024894.
Millbont Pharmaceuticals reported revenue of ₹1.7 Cr for FY 2025 (down 12% YoY).
Millbont Pharmaceuticals has 5 current directors:
- Harsh Gupta - Director
- Arvind Kumar Gupta - Director
- Dinesh Kumar Gupta - Director
- Anant Gupta - Director
- Kalpana Gupta - Director
Millbont Pharmaceuticals reported a net profit of ₹30.21 Lakh (net margin 17.7%) and EBITDA of ₹44.25 Lakh (EBITDA margin 26%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Millbont Pharmaceuticals is -1% over three years and -1% over five years. In the latest year (FY 2025) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Millbont Pharmaceuticals is 08AAFCM2272E1ZN, registered in Rajasthan.
The CIN (Corporate Identification Number) of Millbont Pharmaceuticals is U24232RJ2007PTC024894. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Millbont Pharmaceuticals was incorporated on 24 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Millbont Pharmaceuticals by revenue are Raghav Sai Pharmaceuticals Pvt.Ltd, Suprv Innovations Private Limited, George & Gem's Pharmaceuticals Private Limited, Quora Pharmaceuticals Private Limited, Plus Healthcare Solutions Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Hari Prasad Gupta ceased to be Director on 27 Mar 2024. Harsh Gupta was appointed as Director on 26 Sep 2020. Anant Gupta was appointed as Director on 03 Oct 2014. Millbont Pharmaceuticals has 6 board changes on record in total.
Millbont Pharmaceuticals can be reached through the website millbont.com. Its registered office is in Udaipur, Rajasthan, India.